Previous studies have shown FABP5 up-regulation in various tumors28, indicating that FABP5 is an oncogene that enhances the proliferation, invasiveness, survival, and inflammation in liver cancer31, cervical32,33, colon cancer34, renal cancer35, and breast cancer cells36,37. Here, FABP5 is linked to breast cancer.